Repetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis.
Aurélia Gay, Julien Cabe, Ingrid De Chazeron...
https://pubmed.ncbi.nlm.nih.gov/35160085/Actively Recruiting
Led by Stanford University · Updated on 2025-09-12
30
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the use of deep transcranial magnetic stimulation dTMS as a potential treatment for Veterans with moderate to severe methamphetamine use disorder MUD. This study investigates a novel approach using H4 coils designed to target deeper and broader brain areas, including the bilateral insula, which is part of the brains salience network associated with addiction and relapse risk. The goal is to better understand how this innovative brain stimulation may influence brain function and treatment outcomes for MUD. Participants will be randomly assigned to receive either active dTMS or sham dTMS using the H4 coil. Treatments consist of 30 sessions administered three times daily over 10 consecutive business days, with each session lasting about 30 minutes. The active coil aims to modulate key brain circuits involved in addiction, while the sham coil provides a comparison to evaluate the true effects of the stimulation. During the study, participants will undergo assessments shortly after treatment to evaluate insula function and other salience network activity. Researchers will also track the percentage of days participants remain abstinent and whether relapse occurs over a three-month period following treatment. The study includes careful monitoring to ensure participants safety and adherence, with a total participation timeline extending at least three months after treatment.
CONDITIONS
Deep TMS of Neural Circuits Associated With Stimulant Use Disorder
S
Samantha Ward, BS
E
Eileen G Fischer, BS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Stanford University
Lead Sponsor
VA Palo Alto Health Care System
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Active dTMS | Sham dTMS |
|---|---|---|
| What it is | Active deep transcranial magnetic stimulation (dTMS) is delivered with the H4 coil to target the bilateral insula, aiming to modulate neural circuits linked to stimulant use disorder. | Sham dTMS uses the same coil and procedure but does not deliver active magnetic stimulation, serving as a control for comparison. |
| Role in trial | This arm tests whether active dTMS to the insula reduces symptoms or changes brain function related to methamphetamine use disorder. | The sham group allows assessment of the effects of active stimulation by comparison, controlling for procedure-related effects. |
| Primary use | Investigational device-based intervention intended to reduce craving and relapse in methamphetamine use disorder. | Serves as the inactive comparator to determine the specific effects attributable to active dTMS. |
| How it is given or performed | Participants receive active dTMS using the H4 coil on the scalp, targeting both sides of the insula region under controlled clinic conditions. | Participants undergo an identical procedure with the H4 coil placed on the scalp, but without delivering real magnetic stimulation. |
| Evidence status | Clinical investigation of deep TMS for stimulant use disorder is ongoing. Recent meta-analyses suggest repetitive TMS (including deep TMS) may reduce craving in stimulant and behavioral addictions, but broader evidence for methamphetamine use disorder is still emerging. | Sham dTMS does not actively stimulate the brain and is not expected to reduce symptoms beyond possible placebo effects. |
| Important limitations | Long-term benefit, safety profile, and relapse rates after dTMS in methamphetamine use disorder are not well established. Published evidence remains limited; more studies are needed to determine its role in routine care. | Sham procedures may not perfectly mimic all sensations of active dTMS, so blinding effectiveness could vary. Sham dTMS is not a treatment. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 10 consecutive business days
Participants receive 30 active or sham Deep Transcranial Magnetic Stimulation (dTMS) sessions targeting the bilateral insula, administered 3 times per day over 10 consecutive business days. Each treatment visit lasts approximately 30 minutes.
30 treatment visits (in-person)
Duration - Up to 3 months post-treatment
Participants are monitored for treatment outcomes and relapse risk up to 3 months after completing treatment.
Visits at 1 to 4 days and 3 months post-treatment
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Aurélia Gay, Julien Cabe, Ingrid De Chazeron...
https://pubmed.ncbi.nlm.nih.gov/35160085/Maayan Harel, Irene Perini, Robin Kämpe...
https://pubmed.ncbi.nlm.nih.gov/35067356/George F Koob, Nora D Volkow
https://pubmed.ncbi.nlm.nih.gov/19710631/Sarah K Peters, Katharine Dunlop, Jonathan Downar
https://pubmed.ncbi.nlm.nih.gov/28082874/Stanford University
Lead Sponsor
VA Palo Alto Health Care System
Collaborating Sponsor